{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:37:22Z","timestamp":1790105842716,"version":"4.0.1"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100004699","name":"Chung Shan Medical University Hospital","doi-asserted-by":"publisher","award":["CSH-CMCTC-101-002"],"award-info":[{"award-number":["CSH-CMCTC-101-002"]}],"id":[{"id":"10.13039\/501100004699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Rheum Dis"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1111\/1756-185x.12986","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T13:00:09Z","timestamp":1481374809000},"page":"363-370","source":"Crossref","is-referenced-by-count":31,"title":["Sulfasalazine might reduce risk of cardiovascular diseases in patients with ankylosing spondylitis: A nationwide population-based retrospective cohort study"],"prefix":"10.1111","volume":"20","author":[{"given":"Hong-Wei","family":"Tam","sequence":"first","affiliation":[{"name":"School of Medicine; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Jieh","family":"Yeo","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Rheumatology; Chung Shan Medical University Hospital; Tai Chung Taiwan"},{"name":"Institute of Medicine; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui-Ying","family":"Leong","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Rheumatology; Chung Shan Medical University Hospital; Tai Chung Taiwan"},{"name":"Institute of Medicine; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hsi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Chao","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ming","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Medicine; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Research; Chung Shan Medical University Hospital; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Yuan","family":"Chiou","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Rheumatology; Chung Shan Medical University Hospital; Tai Chung Taiwan"},{"name":"Institute of Medicine; Chung Shan Medical University; Tai Chung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"10.1111\/1756-185X.12986-BIB0001|apl12986-cit-0001","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.12986-BIB0002|apl12986-cit-0002","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.21577","article-title":"Incidence and prevalence of ankylosing spondylitis in Northern Norway","volume":"53","author":"Bakland","year":"2005","journal-title":"Arthritis Care Res"},{"key":"10.1111\/1756-185X.12986-BIB0003|apl12986-cit-0003","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-5699(90)90051-A","article-title":"Guilt by association: HLA-B27 and ankylosing spondylitis","volume":"11","author":"Benjamin","year":"1990","journal-title":"Immunol Today"},{"issue":"4","key":"10.1111\/1756-185X.12986-BIB0004|apl12986-cit-0004","doi-asserted-by":"crossref","first-page":"e94027","DOI":"10.1371\/journal.pone.0094027","article-title":"Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1111\/1756-185X.12986-BIB0005|apl12986-cit-0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis","volume":"63","author":"Mathieu","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1111\/1756-185X.12986-BIB0006|apl12986-cit-0006","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K","article-title":"Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug","volume":"44","author":"Dougados","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1756-185X.12986-BIB0007|apl12986-cit-0007","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/1756-185X.12986-BIB0008|apl12986-cit-0008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/ard.2007.075309","article-title":"Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study","volume":"67","author":"Sieper","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1756-185X.12986-BIB0009|apl12986-cit-0009","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor \u03b1","volume":"346","author":"Gorman","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/1756-185X.12986-BIB0010|apl12986-cit-0010","unstructured":"World Health Organization Collaborating centre for drug statistics methodology http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/"},{"key":"10.1111\/1756-185X.12986-BIB0011|apl12986-cit-0011","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/1756-185X.12986-BIB0012|apl12986-cit-0012","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/1756-185X.12986-BIB0013|apl12986-cit-0013","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the class study: a randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1111\/1756-185X.12986-BIB0014|apl12986-cit-0014","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/CS20040326","article-title":"Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation","volume":"109","author":"Divecha","year":"2005","journal-title":"Clin Sci"},{"key":"10.1111\/1756-185X.12986-BIB0015|apl12986-cit-0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","article-title":"Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population","volume":"52","author":"Garc\u00eda Rodr\u00edguez","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1111\/1756-185X.12986-BIB0016|apl12986-cit-0016","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1111\/1756-185X.12986-BIB0017|apl12986-cit-0017","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/1756-185X.12986-BIB0018|apl12986-cit-0018","first-page":"531","article-title":"Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis-a single centre study using non-biologic drugs","volume":"61","author":"Chatterjee","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"10.1111\/1756-185X.12986-BIB0019|apl12986-cit-0019","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ehjcvp\/pvv021","article-title":"Exploring the potential of low-dose sulfasalazine in stable coronary artery disease patients: randomized, double-blind, placebo-controlled study","volume":"1","author":"Vohra","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1111\/1756-185X.12986-BIB0020|apl12986-cit-0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.12986","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.12986","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/1756-185X.12986\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:40:01Z","timestamp":1625496001000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.12986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1111\/1756-185x.12986","archive":["Portico"],"relation":{},"ISSN":["1756-1841"],"issn-type":[{"value":"1756-1841","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12,10]]}}}